Brightgene Bio-medical Technology Co., Ltd.

This study tests a new medicine called BGM0504 against a well-known drug, semaglutide, in people with type 2 diabetes. All participants take metformin and then receive either BGM0504 or semaglutide once a week. The main goal is to see which drug lowers blood sugar more after 24 w…

This early-stage study tests a new drug called BGM1812 in 60 overweight or obese but otherwise healthy adults. The goal is to check the drug's safety, how the body processes it, and whether it leads to weight loss. Participants receive either the drug or a placebo injection under…

This early-stage study tests an experimental daily pill, BGM0504, in 80 non-diabetic adults who are overweight or obese. The main goal is to check safety and how the body processes the drug, while also measuring weight changes over 11 weeks. Participants are randomly assigned to …

This study tests a new drug called BGM0504 against an existing weight-loss medication, tirzepatide, in adults with obesity. About 90 participants who do not have diabetes will take one of the two drugs for 26 weeks. The main goal is to see how much weight they lose and whether th…

This early-stage study tests a new drug called BGM1812 in healthy and non-diabetic overweight or obese Chinese adults. The main goal is to check if the drug is safe and tolerable, and to see how it behaves in the body. About 60 participants will receive either the drug or a place…

This early-stage study tests a new pill called BGM0504 in healthy and overweight or obese adults who do not have diabetes. The main goal is to check the drug's safety and how the body handles it. Researchers will also measure weight changes over 8 weeks. The study involves 75 par…

This study checks if a new multi-dose pen version of the BGM0504 injection works the same as the single-dose version in overweight or obese adults. About 144 people aged 18-55 with a BMI of 24 or higher will get one shot and have their blood levels measured. The goal is to see if…

This study looks at how a high-fat meal and different ways of taking the drug BGM0504 affect its levels in the body. It involves 144 healthy Chinese adults aged 18 to 55. The goal is to understand the drug's behavior and safety, not to treat any disease.